Age >70 + ECOG ≥3 OR severe cytopenia at diagnosis — mLSG-15 intensive chemotherapy exces...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-ATLL-FRAILTY-AGE |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-ATLL |
| Sources | SRC-ESMO-PTCL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Age >70 + ECOG ≥3 OR severe cytopenia at diagnosis — mLSG-15 intensive chemotherapy excessive toxicity; CHOP-based or AZT+IFN-α (even in aggressive subtype) considered. |
|---|---|
| Clinical direction | de-escalate |
| Category | frailty-age |
Trigger Logic
{
"all_of": [
{
"comparator": ">=",
"finding": "ecog_status",
"threshold": 3
},
{
"comparator": ">",
"finding": "age_years",
"threshold": 70
}
],
"type": "composite_clinical"
}
Notes
ATLL endemic in older Japanese/Caribbean populations; mLSG-15 trials excluded >70. Real-world elderly aggressive ATLL often gets dose-reduced CHOP at best.
Used By
No reverse references found in the YAML corpus.